Fresenius Medical Care Sees U.S. Plans for Kidney Disease as Positive
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
We are actively monitoring the novel coronavirus (COVID-19) pandemic. Learn About the steps that we are taking to protect our patients, employees, physicians, and partners. If you are a patient with questions or concerns, please find additional information at FreseniusKidneyCare.com and AzuraVascularCare.com
Our NxStage System One with NxView empowers nurses to focus on patients instead of tech. The simple, versatile system delivers renal replacement therapy throughout a patient's stay in the ICU.
We're working every day to transform extracorporeal life support. Now, we're set to bring the same passion for research, technology, and patient care to the treatment of heart and lung conditions. Watch this space for more information. In the meantime, read this informative Q&A about our forthcoming extracorporeal support device, Novalung™. Pending 510(k) clearance – Not for sale in the US.
© 2019, Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, Novalung, NxStage, NxView, and System One are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. P/N 103878-01 Rev A 10/2019